Appointment of new Members of the Supervisory Board of Ryvu Therapeutics S.A.
Read More
Shareholders controlling at least 5% of the votes at the General Shareholders Meeting of Ryvu Therapeutics S.A. convened on June 14th, 2023
Read More
Resolutions adopted by the General Shareholders Meeting of Ryvu Therapeutics S.A.
Read More
Recommendation of Ryvu’s project for funding by the Medical Research Agency
Read More
Publication of the updated clinical and preclinical data on RVU120
Read More
Correction of the current report on the convening of the Company’s Annual General Meeting
Read More
Notification from person discharging managerial responsibilities in the Company due to execution of the Stock Grant Program
Read More
Notification from person discharging managerial responsibilities in the Company due to execution of the Stock Grant Program
Read More
Notification from person discharging managerial responsibilities in the Company due to execution of the Stock Grant Program
Read More
Notification from person discharging managerial responsibilities in the Company due to execution of the Stock Grant Program – Article 19 of MAR
Read More
Notification from a person discharging managerial responsibilities in the Company – Article 19 of MAR
Read More
Convening the Ordinary General Shareholders Meeting of Ryvu Therapeutics S.A.
Read More
Notification from PTE Allianz Polska S.A. of a change in its share in the total number of votes in the Company
Read More
Ryvu Therapeutics S.A. Q1 2023 Financial Report
Read More
New clinical and preclinical data on RVU120 to be presented at the upcoming 2023 European Hematology Association Congress
Read More
Conclusion of an agreement for the issuance of subscription warrants to the European Investment Bank
Read More
Conclusion of the agreements concerning Phase II start-up services for RVU120 clinical studies in AML/HR-MDS
Read More
Notification from a person discharging managerial responsibilities in the Company – Article 19 of MAR
Read More
Notice of termination regarding Option, License and Collaboration Agreement with Galapagos NV
Read More
Change of publication date of the annual report for 2022
Read More
